A treatment for myasthenia gravis, a rare muscle wasting condition ... shortness of breath and weakness in the neck, arms and legs. Symptoms usually start in women under 40 and men over 60, but the ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

SCOTTSDALE, Ariz. — June 16, 2025 — The first patient enrolled in a planned international clinical trial has been treated at HonorHealth Research Institute with a new type of immune therapy for those ...

Myasthenia gravis affects both men and women and occurs across all races and ethnicities. Its incidence and prevalence are higher in women under age 50 and in men ages 65 and older.

About 80%-90% of patients with generalized myasthenia gravis (gMG) have anti-AChR antibodies, and they’re the ones being targeted in UCB’s campaign. “Most commonly, gMG impacts women 30-50 ...

Efgartigimod significantly reduced immunoglobulin use, with 95% reduction in annual courses and 84-97% of patients stopping use post-initiation. Hospitalizations, exacerbations, and crisis events ...

The condition affects approximately 14 to 20 of every 100,000 people in the United States. Although myasthenia gravis can occur at any age, it is more common among women younger than 40 and men older ...

Myasthenia Gravis By Carrie Dennett, MPH, RDN ... Anyone can be diagnosed with MG, though it’s more common in adults than children, especially in women under 40 and men over 60. It’s also slightly ...

Data from the Phase III MINT trial found that Uplizna demonstrated a greater reduction in Myasthenia Gravis Activities of Daily Living score compared to placebo at week 26. Results from the Phase III ...

If you have myasthenia gravis and are not diagnosed and treated, you will continue to experience symptoms. Other Similar Conditions Conditions that produce symptoms similar to those of myasthenia ...

The prevalence and incidence of gMG are increasing worldwide. 6 There are between 80,000 and 100,000 patients with myasthenia gravis in the U.S. 7,8 Approximately 85% of patients with myasthenia ...